Copyrighting Musical Fountains: An Analysis of China’s Approach to Dynamic...
We’re pleased to bring to you a guest post by Abhijay Srekanth, discussing a Chinese decision on copyrightability of a musical water fountain show and analysing whether the courts’ approach therein is...
View ArticleNLSIU Announces Thakur Foundation PhD Scholarships in Public Health & the Law
We’re pleased to inform you that the National Law School of India University (NLSIU), Bangalore has announced two PhD scholarships on public health and the law, supported by the Thakur Foundation. For...
View ArticleSupreme Court Weighs in on the Crisis: Vaccine Price Equity, Compulsory...
Supreme Court of India After being heavily criticized for taking matters into its own hands by transferring matters related to the Covid-19 crisis from High Courts, the Supreme Court had its first...
View ArticleSpicyIP Weekly Review (April 26- May 2)
Topical Highlight Supreme Court Weighs in on the Crisis: Vaccine Price Equity, Compulsory Licensing and Free Speech Online In this post, Adyasha analyses the recent proceedings in the suo motu case...
View ArticleNLU Delhi’s Online Panel Discussion on ‘IP and the Pandemic’ [May 5]
We’re pleased to inform you that the DPIIT IPR Chair at NLU Delhi is organising an online panel discussion on ‘IP and the Pandemic’ on May 5, 2021. For details, please see the announcement below: NLU...
View ArticleSC Issues Interim Order in Suo Motu COVID-19 Case: Raises Questions on...
Representative image of Covid vaccine (from here) A couple of days ago, I wrote about the Supreme Court’s first hearing in the suo motu Covid-19 case that took place on 30th April, discussing the...
View ArticleNatco Files Compulsory Licence Application for Covid Drug Baricitinib
In an interesting development, Natco has approached the Controller of Patents for a Compulsory Licence under Section 92 of the Patents Act, for the drug Baricitinib. The 12 page application is...
View ArticleDelhi HC Issues Order on Tocilizumab Shortage, Seeks Patent Working...
A 20 ml vial of tocilizumab, marketed by Cipla (image from here) This evening, the Delhi High Court passed an interim order issuing important directions on the shortage of the drug Tocilizumab in Delhi...
View ArticleIn Major Turnaround, US Announces Support for IP Waiver of Covid Vaccines
Late last night, the new US Trade Representative Katherine Tai, announced that the Biden-Harris administration is now supporting the waiver of IP protections for Covid-19 Vaccines. The short statement...
View ArticleBombay HC Rejects Injunction Plea in Passing Off Action against Serum...
A vial of Covishield vaccine beside a syringe (image from here) Recently, a Nanded-based pharmaceutical company, Cutis Biotech (‘Cutis’), had filed a passing off suit against Serum Institute of India...
View ArticleFreedom of Panorama: Analysing the Term ‘Permanently Situate’ under the...
Wrapped Reichstag building in Berlin, Germany (image from here) We’re pleased to bring you a guest post by Priya Garg, Ghanavi Umesh and Rishika Agarwal, analysing the meaning of the term ‘permanently...
View ArticlePay/‘Pe’ Charcha: Delhi High Court’s Decision in PhonePe v. BharatPe...
We’re pleased to bring to you a guest post by Abhinav Hansaraman, analysing the interim order recently issued by the Delhi High Court in a trademark infringement and passing off dispute between online...
View ArticleSpicyIP Weekly Review (May 3 – 9)
Topical Highlights Pic of package cover for olumiant baricitinib Natco Files Compulsory Licence Application for Covid Drug Baricitinib? Swaraj wrote about Natco’s application for a compulsory license...
View ArticleCentre Sees No Compulsion to Issue Compulsory Licenses for Covid Drugs
Image from here May 2021 has been an interesting month so far for compulsory licenses. First the Supreme Court inquired about the Government’s position on issuing CLs for COVID-19 related drugs and...
View ArticleSpecial 301 Report 2021: US’s Great U-turn on Compulsory Licensing
USTR logo Lost in the shadow of the US’s historic change of position on Waiver of IP rights in Covid-19 vaccines, the USTR’s latest Annual Special 301 Report has its own share of surprises to offer....
View ArticleEarning Royalties off Covaxin While Demanding IP Waiver at the WTO: Saviour...
Image from here As news broke out on May 3, 20201 regarding the Indian Council of Medical Research (ICMR) earning royalties out of every dose of Covaxin sold, many were quick to chide the government...
View ArticleSpecial 301 Report 2021: Copyrights, Enforcement, and the Same Old Complaints
USTR logo The Office of the United States Trade Representative (‘USTR’) recently released its Annual Special 301 Report on Intellectual Property Protection (‘Report’). To borrow Swaraj’s description of...
View ArticleIndia’s First Anti-Anti-Suit Injunction (A2SI) Order: A Missed Opportunity...
We’re pleased to bring to you a guest post by our former blogger Rajiv Choudhry, discussing the recent Delhi High Court order granting an anti-anti-suit injunction in favour of InterDigital in a SEP...
View ArticleIndia’s First Anti-Anti-Suit Injunction (A2SI) Order: A Missed Opportunity...
We’re pleased to bring to you a two-part guest post by our former blogger Rajiv Choudhry, discussing the recent Delhi High Court order granting an anti-anti-suit injunction in favour of InterDigital....
View ArticleCompulsion for Compulsory Licenses for Covid Vaccines Climbs: But Are They...
This is not how our public policy works…. hopefully! Image from here On 11th May, it was reported that Kerala High Court has sought a response from the Central government on a PIL seeking direction to...
View Article